Former heavyweight champion Mike Tyson won't face criminal charges after punching a man multiple times before a flight out of San Francisco last month. The announcement came Tuesday following an investigation by the San Mateo County District Attorney’s Office, which says the circumstances preceding the April 20 confrontation led to the decision. “The circumstances include the conduct of the victim leading up to the incident, the interaction between Mr. Tyson and the victim, as well as the requests of both the victim and Mr. Tyson that no charges be filed in the case,” District Attorney Stephen...
Stories Chosen For You
Herschel Walker, the Georgia Republican candidate running for the U.S. Senate endorsed by former President Donald Trump, is facing scrutiny for failing to report more than $3 million in earnings over a five-month period as part of his federal financial disclosure.
According to Business Insider: "Walker's original candidate report, filed in December 2021, listed him and his spouse cumulatively earning $927,886 from late 2020 to the end of 2021 through various corporations, including a $100,000 salary from 'Renaissance Man Food Services, LLC.'"
Five months after filing the original candidate report, Walker reportedly amended it to include that he'd garnered an additional $3.2 million through a company called "H. Walker Enterprises." Business Insider's review of the amended documents indicates that he "amended his overall income in the disclosure to $4.1 million, more than four times higher than the original candidate report."
Per the H. Walker Enterprises' website, the company stated that its mission is to "establish a business structure capable of servicing food service, corporate and retail customers with a variety of products on a national level." However, it remains unclear what Walker's role is within the company as his campaign report describes the "partnership distributions."
Speaking to Business Insider, Dylan Hedtler-Gaudette, who serves as the government affairs manager for the Project on Government Oversight, weighed in on Walker amending his reports. According to Hedtler-Gaudette, Walker's decision to do so at such a late point on the campaign trail "undermines 'the basic compact between a person running for office and the people they are trying to recruit to support them.'"
"There's some potential a voter who may find him supportable may have already contributed some money on the basis of the information they had at that point," Hedtler-Gaudette said. "But as we're seeing now, that information was incomplete."
Under the laws stated in the U.S. Senate Select Committee on Ethics, all candidates are required to submit candidate reports that disclose "their honoraria payments, income, assets, liabilities, compensation, and other personal financial details within 30 days of becoming a candidate," per Insider.
Candidates that do not may face a number of different penalties including but not limited to a fine or an inquiry launched by the U.S Department of Justice (DOJ).
Controversial Rep. Madison Cawthorn lashed out at his critics on Thursday after Republican voters made him the youngest member of Congress to lose a primary.
Cawthorn took to Instagram where he posted a photo of the people who stood with him.
"When the establishment turned their guns on me, when the Uni-party coalesced to defeat an America First member very few people had my back. This list includes the lion share of figures that came to my defense when it was not politically profitable," he wrote.
The list included Sen. Rand Paul (R-KY), Reps. Matt Gaetz (R-FL), Paul Gosar (R-AZ), and Marjorie Taylor Greene (R-GA), along with Fox News personality Tucker Carlson and Steve Bannon, among others.
"These are honorable men and women who are the type of friends anyone yearns to have," he claimed.
Cawthorn said he has a new mission in life.
"There are other National figures who I believe are patriots, but I am on a mission now to expose those who say and promise one thing yet legislate and work towards another, self-profiteering, globalist goal. The time for gentile (sic) politics as usual has come to an end," he wrote. "It’s time for the rise of the new right, it’s time for Dark MAGA to truly take command."
"We have an enemy to defeat, but we will never be able to defeat them until we defeat the cowardly and weak members of our own party. Their days are numbered. We are coming," he warned.
Retailers nationwide reported supplies of baby formula were out of stock at a rate of 43% during the week ended May 8, 2022, compared with less than 5% in the first half of 2021. In some states, such as Texas and Tennessee, shortages were over 50%, which has prompted parents to travel long distances and pay exorbitant sums of money to grab dwindling supplies of formula for their babies.
News that the Food and Drug Administration and Similac-maker Abbott have reached a deal to reopen the formula factory in Sturgis, Michigan, is welcome news for desperate parents, but it will do little to alleviate the shortage anytime soon. This is in no small part because of the very nature of America’s baby formula industry.
I research and teach supply chain management, with a special focus on the health care industry. The closure of the Similac factory may have lit the fuse for the nationwide shortage, but a combination of government policy, industry market concentration and supply chain issues supplied the powder.
What prompted the baby formula shortage
On Feb. 17, Abbott initiated a voluntary recall after four infants were hospitalized with infections from the bacteria Cronobacter sakazakii – two of them died – after consuming baby formula manufactured in their Sturgis facility. The factory was also shut down.
The FDA has identified no new cases but has not yet approved reopening the Sturgis facility, which is responsible for about half of Abbott’s U.S. supply. Abbott said it entered into a consent decree with the FDA that paves the way to reopening the facility once certain conditions are met.
Shortages of baby formula have led major U.S. retailers including Target, CVS, Walgreens and Kroger to restrict the amount of formula a consumer may purchase. These shortages are disproportionately hurting low-income families and those who do not have the resources to travel long distances to find alternative sources of baby formula.
The root of the problem begins with a concentration of production.
Two companies – Abbott and Reckitt Benckiser, which makes Enfamil – dominate the industry with about 80% of the U.S. market. Nestlé, which sells baby formula in the U.S. under its Gerber brand, controls another 10%.
Part of the reason these companies are so entrenched in their position is that Abbott, Reckitt and Nestlé are the only makers approved by the U.S. government to provide baby formula through the Special Supplemental Nutrition Program for Women, Infants and Children, known as WIC, which provides supplemental food to low-income families.
WIC, which reimburses companies at 15% of the wholesale cost, is responsible for 92% of supermarket sales of milk-based powder formula in 12-to 16-ounce containers and 51% of all sales in other sizes.
The federal government provides WIC grants to each state, which then contracts with one of the three companies. While WIC is a critical program to feed the most vulnerable, government support of this program has the unintended consequence of creating a de facto monopoly in each state.
The amount of WIC funding to these three established companies makes it difficult for any startup to make significant inroads in the baby formula industry. There is little chance they can capture the market share necessary to justify a significant investment. Since only a handful of manufacturing facilities are approved for production of baby formula in the U.S., startups don’t have the volume required to produce in these facilities.
Another reason for the intense concentration is import controls.
About 98% of the formula consumed in the U.S. is produced domestically, whether by a U.S. or international company. While facilities abroad such as those in Mexico, Chile, Ireland and the Netherlands meet the FDA’s nutrition standards, a failure to meet its labeling guidelines prevents them from exporting to the U.S. As a result, some consumers order unapproved formula over the internet from Europe and elsewhere, which may then be confiscated at the border.
International manufactures also face high tariffs, which can be as high as 17.5% depending on volume. That’s one reason Canadian producers, which are subsidized by their government, have mostly steered clear of the U.S. market. And the United States Mexico Canada Agreement, which came into force in 2020, included a provision that made it even harder for Canada to ship baby formula south in an effort to protect domestic producers.
‘Lean’ supply chains
The pandemic-related problems that have beleaguered global supply chains have also played a role.
Like in other industries, baby formula makers have long tried to make their supply chains as “lean” and efficient as possible. That means they aimed to minimize the amount of time baby formula spent sitting – unprofitably – on warehouse shelves and send the goods from factory to retailer as quickly as possible. The problem is that when there’s a surge in demand or a drop in supply, shortages can result. The leaner the supply chain, the larger the potential disruption.
The WIC program also encourages a lean supply chain because it reimburses just 15% of the wholesale price. The huge volume means the companies can still be profitable, but the lower margins per sale encourage them to keep a very efficient supply chain.
In March 2020, formula sales surged as people stockpiled pretty much everything. But that led sales to drop as parents worked through all that extra formula. That prompted makers to reduce production. And now in 2022, demand jumped again, especially after reports spread of the Similac recall. And with demand soaring and supply down significantly because of the Sturgis plant’s closure, shortages were inevitable.
Shortage is far from over
Both the Biden administration and companies have announced a variety of measures to end the shortage.
The FDA is expected to soon announce the loosening of import rules for baby formula, and some states are allowing WIC recipients to use their rebates to buy formula from companies other than the one on the contract. Abbott has already agreed to honor rebates for competitor products in states where they have WIC contracts.
The best way to end the shortage – getting the Sturgis plant online and its formula on retail shelves – will take two months.
Ultimately, preventing this kind of situation from happening again will require changes to government policy and business practices. I believe the government’s de facto monopolies should be opened up to more competition. And formula makers may just have to accept a little less profit from supply chain efficiencies as a cost of doing business – and as a way to ensure families won’t again be faced with the loss of a product so vital to their babies’ survival.